410 related articles for article (PubMed ID: 25072865)
1. A key role of the mitochondrial citrate carrier (SLC25A1) in TNFα- and IFNγ-triggered inflammation.
Infantino V; Iacobazzi V; Menga A; Avantaggiati ML; Palmieri F
Biochim Biophys Acta; 2014 Nov; 1839(11):1217-1225. PubMed ID: 25072865
[TBL] [Abstract][Full Text] [Related]
2. The Mitochondrial Citrate Carrier SLC25A1/CIC and the Fundamental Role of Citrate in Cancer, Inflammation and Beyond.
Mosaoa R; Kasprzyk-Pawelec A; Fernandez HR; Avantaggiati ML
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33499062
[TBL] [Abstract][Full Text] [Related]
3. The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer.
Fernandez HR; Gadre SM; Tan M; Graham GT; Mosaoa R; Ongkeko MS; Kim KA; Riggins RB; Parasido E; Petrini I; Pacini S; Cheema A; Varghese R; Ressom HW; Zhang Y; Albanese C; Üren A; Paige M; Giaccone G; Avantaggiati ML
Cell Death Differ; 2018 Jul; 25(7):1239-1258. PubMed ID: 29651165
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor necrosis factor-alpha-inducible inflammatory genes by interferon-gamma is associated with altered nuclear factor-kappaB transactivation and enhanced histone deacetylase activity.
Keslacy S; Tliba O; Baidouri H; Amrani Y
Mol Pharmacol; 2007 Feb; 71(2):609-18. PubMed ID: 17108260
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic mutations of the human mitochondrial citrate carrier SLC25A1 lead to impaired citrate export required for lipid, dolichol, ubiquinone and sterol synthesis.
Majd H; King MS; Smith AC; Kunji ERS
Biochim Biophys Acta Bioenerg; 2018 Jan; 1859(1):1-7. PubMed ID: 29031613
[TBL] [Abstract][Full Text] [Related]
6. Acetylation of human mitochondrial citrate carrier modulates mitochondrial citrate/malate exchange activity to sustain NADPH production during macrophage activation.
Palmieri EM; Spera I; Menga A; Infantino V; Porcelli V; Iacobazzi V; Pierri CL; Hooper DC; Palmieri F; Castegna A
Biochim Biophys Acta; 2015 Aug; 1847(8):729-38. PubMed ID: 25917893
[TBL] [Abstract][Full Text] [Related]
7. SLC25A1 promotes tumor growth and survival by reprogramming energy metabolism in colorectal cancer.
Yang Y; He J; Zhang B; Zhang Z; Jia G; Liu S; Wu T; He X; Wang N
Cell Death Dis; 2021 Nov; 12(12):1108. PubMed ID: 34839347
[TBL] [Abstract][Full Text] [Related]
8. New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation.
Santarsiero A; Leccese P; Convertini P; Padula A; Abriola P; D'Angelo S; Bisaccia F; Infantino V
Mediators Inflamm; 2018; 2018():1419352. PubMed ID: 30050389
[TBL] [Abstract][Full Text] [Related]
9. IFNγ potentiates TNFα/TNFR1 signaling to induce FAT10 expression in macrophages.
Kandel-Kfir M; Garcia-Milan R; Gueta I; Lubitz I; Ben-Zvi I; Shaish A; Shir L; Harats D; Mahajan M; Canaan A; Kamari Y
Mol Immunol; 2020 Jan; 117():101-109. PubMed ID: 31759325
[TBL] [Abstract][Full Text] [Related]
10. Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB.
Ohmori Y; Schreiber RD; Hamilton TA
J Biol Chem; 1997 Jun; 272(23):14899-907. PubMed ID: 9169460
[TBL] [Abstract][Full Text] [Related]
11. Interferon gamma (IFNgamma ) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNgamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways.
Suk K; Chang I; Kim YH; Kim S; Kim JY; Kim H; Lee MS
J Biol Chem; 2001 Apr; 276(16):13153-9. PubMed ID: 11278357
[TBL] [Abstract][Full Text] [Related]
12. IFNγ and TNFα synergistically induce apoptosis of mesenchymal stem/stromal cells via the induction of nitric oxide.
Li X; Shang B; Li YN; Shi Y; Shao C
Stem Cell Res Ther; 2019 Jan; 10(1):18. PubMed ID: 30635041
[TBL] [Abstract][Full Text] [Related]
13. Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2-hydroxyglutaric aciduria.
Nota B; Struys EA; Pop A; Jansen EE; Fernandez Ojeda MR; Kanhai WA; Kranendijk M; van Dooren SJ; Bevova MR; Sistermans EA; Nieuwint AW; Barth M; Ben-Omran T; Hoffmann GF; de Lonlay P; McDonald MT; Meberg A; Muntau AC; Nuoffer JM; Parini R; Read MH; Renneberg A; Santer R; Strahleck T; van Schaftingen E; van der Knaap MS; Jakobs C; Salomons GS
Am J Hum Genet; 2013 Apr; 92(4):627-31. PubMed ID: 23561848
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH.
Tan M; Mosaoa R; Graham GT; Kasprzyk-Pawelec A; Gadre S; Parasido E; Catalina-Rodriguez O; Foley P; Giaccone G; Cheema A; Kallakury B; Albanese C; Yi C; Avantaggiati ML
Cell Death Differ; 2020 Jul; 27(7):2143-2157. PubMed ID: 31959914
[TBL] [Abstract][Full Text] [Related]
15. A critical role for citrate metabolism in LPS signalling.
O'Neill LA
Biochem J; 2011 Sep; 438(3):e5-6. PubMed ID: 21867483
[TBL] [Abstract][Full Text] [Related]
16. SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker.
Kolukula VK; Sahu G; Wellstein A; Rodriguez OC; Preet A; Iacobazzi V; D'Orazi G; Albanese C; Palmieri F; Avantaggiati ML
Oncotarget; 2014 Mar; 5(5):1212-25. PubMed ID: 24681808
[TBL] [Abstract][Full Text] [Related]
17. C/EBPbeta mediates synergistic upregulation of gene expression by interferon-gamma and tumor necrosis factor-alpha in bone marrow-derived mesenchymal stem cells.
Xu G; Zhang Y; Zhang L; Roberts AI; Shi Y
Stem Cells; 2009 Apr; 27(4):942-8. PubMed ID: 19353522
[TBL] [Abstract][Full Text] [Related]
18. The mitochondrial citrate carrier: a new player in inflammation.
Infantino V; Convertini P; Cucci L; Panaro MA; Di Noia MA; Calvello R; Palmieri F; Iacobazzi V
Biochem J; 2011 Sep; 438(3):433-6. PubMed ID: 21787310
[TBL] [Abstract][Full Text] [Related]
19. Combined D2-/L2-hydroxyglutaric aciduria (SLC25A1 deficiency): clinical course and effects of citrate treatment.
Mühlhausen C; Salomons GS; Lukacs Z; Struys EA; van der Knaap MS; Ullrich K; Santer R
J Inherit Metab Dis; 2014 Sep; 37(5):775-81. PubMed ID: 24687295
[TBL] [Abstract][Full Text] [Related]
20. A novel homozygous SLC25A1 mutation with impaired mitochondrial complex V: Possible phenotypic expansion.
Cohen I; Staretz-Chacham O; Wormser O; Perez Y; Saada A; Kadir R; Birk OS
Am J Med Genet A; 2018 Feb; 176(2):330-336. PubMed ID: 29226520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
